Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 26)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Apr-14Stock Traders DailyThomas H Kee Jr.Trading Report for (SRPT). A detailed report, including free correlated market analysis, and updates.10$20  View Abstract
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49  View Abstract
24-Apr-14New Constructs, LLCN/ASRPT: Due Diligence Review: Forensic Earnings and Valuation5$25  View Abstract
23-Apr-14S&P Capital IQ Quantitative ReportN/ASarepta Therapeutics11$126.50  View Abstract
19-Apr-14Reuters Investment ProfileN/ASTAR Pharmaceutical Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
19-Apr-14Stock Traders DailyThomas H Kee Jr.Our Economy without Stimulus; forward observations.102$20  View Abstract
18-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - STAR PHARMACEUTICAL LIMITED (X64-SG)9$25  View Abstract
18-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Sarepta Therapeutics Incorporated42$75  View Abstract
18-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SAREPTA THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for SRPT11$25  View Abstract
Next 16

Independent Reports (Showing 1 to 10 of 26)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Apr-14Stock Traders DailyThomas H Kee Jr.Trading Report for (SRPT). A detailed report, including free correlated market analysis, and updates.10$20View Abstract
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49View Abstract
24-Apr-14New Constructs, LLCN/ASRPT: Due Diligence Review: Forensic Earnings and Valuation5$25View Abstract
23-Apr-14S&P Capital IQ Quantitative ReportN/ASarepta Therapeutics11$126.50View Abstract
19-Apr-14Reuters Investment ProfileN/ASTAR Pharmaceutical Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
19-Apr-14Stock Traders DailyThomas H Kee Jr.Our Economy without Stimulus; forward observations.102$20View Abstract
18-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - STAR PHARMACEUTICAL LIMITED (X64-SG)9$25View Abstract
18-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Sarepta Therapeutics Incorporated42$75View Abstract
18-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SAREPTA THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for SRPT11$25View Abstract
Next 16

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.